Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin M. Parry; Ignaty Leshchiner; Romain Guièze; Connor Johnson; Eugen Tausch; Sameer A. Parikh; Camilla K. Lemvigh; Julien Broséus; Sébastien Hergalant; Conor Messer; Filippo Utro; Chaya Levovitz; Kahn Rhrissorrakrai; Liang Li; Daniel Rosebrock; Shanye Yin; Stephanie Deng; Kara Slowik; Raquel A. Jacobs; Teddy Huang; Shuqiang Li; Geoff Fell; Robert Redd; Ziao Lin; Binyamin A. Knisbacher; Dimitri Livitz; Christof Schneider; Neil Ruthen; Liudmila Elagina; Amaro Taylor‐Weiner; Bria Persaud; Aina Zurita Martinez; Stacey M. Fernandes; Noelia Purroy; Annabelle Anandappa; Jialin Ma; Julian M. Hess; Laura Z. Rassenti; Thomas J. Kipps; Nitin Jain; William G. Wierda; Florence Cymbalista; Pierre Feugier; Neil E. Kay; Kenneth J. Livak; Brian P. Danysh; Chip Stewart; Donna Neuberg; Matthew S. Davids; Jennifer R. Brown; Laxmi Parida; Stephan Stilgenbauer; Gad Getz; Catherine J. Wu

doi:10.1038/s41591-022-02113-6

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Erin M. Parry(Broad Institute), Ignaty Leshchiner(Broad Institute), Romain Guièze(Broad Institute), Connor Johnson(Broad Institute), Eugen Tausch(Universität Ulm), Sameer A. Parikh(Mayo Clinic), Camilla K. Lemvigh(Dana-Farber Cancer Institute), Julien Broséus(Inserm), Sébastien Hergalant(Inserm), Conor Messer(Broad Institute), Filippo Utro(IBM (United States)), Chaya Levovitz(IBM (United States)), Kahn Rhrissorrakrai(IBM (United States)), Liang Li(Broad Institute), Daniel Rosebrock(Broad Institute), Shanye Yin(Harvard University), Stephanie Deng(Dana-Farber Cancer Institute), Kara Slowik(Broad Institute), Raquel A. Jacobs(Broad Institute), Teddy Huang(Dana-Farber Cancer Institute), Shuqiang Li(Broad Institute), Geoff Fell(Dana-Farber Cancer Institute), Robert Redd(Dana-Farber Cancer Institute), Ziao Lin(Broad Institute), Binyamin A. Knisbacher(Broad Institute), Dimitri Livitz(Broad Institute), Christof Schneider(Universität Ulm), Neil Ruthen(Dana-Farber Cancer Institute), Liudmila Elagina(Broad Institute), Amaro Taylor‐Weiner(Broad Institute), Bria Persaud(Broad Institute), Aina Zurita Martinez(Broad Institute), Stacey M. Fernandes(Dana-Farber Cancer Institute), Noelia Purroy(Broad Institute), Annabelle Anandappa(Harvard University), Jialin Ma(Broad Institute), Julian M. Hess(Broad Institute), Laura Z. Rassenti(National Foundation for Cancer Research), Thomas J. Kipps(National Foundation for Cancer Research), Nitin Jain(The University of Texas MD Anderson Cancer Center), William G. Wierda(The University of Texas MD Anderson Cancer Center), Florence Cymbalista(Inserm), Pierre Feugier(Inserm), Neil E. Kay(Mayo Clinic), Kenneth J. Livak(Dana-Farber Cancer Institute), Brian P. Danysh(Broad Institute), Chip Stewart(Broad Institute), Donna Neuberg(Dana-Farber Cancer Institute), Matthew S. Davids(Harvard University), Jennifer R. Brown(Harvard University), Laxmi Parida(IBM (United States)), Stephan Stilgenbauer(Universität Ulm), Gad Getz(Broad Institute), Catherine J. Wu(Broad Institute)

Nature Medicine

January 1, 2023

10.1038/s41591-022-02113-6

Cited by 81Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis